Trials / Unknown
UnknownNCT02832102
Big Data and Models for Personalized Head and Neck Cancer Decision Support (BD2Decide)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,450 (estimated)
- Sponsor
- Azienda Ospedaliero-Universitaria di Parma · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine new multiscale signatures for the prediction of head and neck cancer (HNC) patients disease outcome, in particular for advanced stage (stage III, IV) human papillomavirus (HPV) negative patients and to validate prognostic models for overall survival.
Detailed description
The clinical study is devoted to the validation of a decision support system for HNC patients management in the frame of a H2020 project.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Standard treatment of SCCHN patients | The interventions may include surgery, radiotherapy, chemotherapy or combined therapies, as recommended by best practice and international guidelines. |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
- First posted
- 2016-07-14
- Last updated
- 2016-07-14
Locations
5 sites across 3 countries: Germany, Italy, Netherlands
Source: ClinicalTrials.gov record NCT02832102. Inclusion in this directory is not an endorsement.